precisionFDA cloud-based genomics platform

The FDA is seeking to award a sole‑source, firm‑fixed‑price IDIQ contract to provide continued operation, sustainment, modernization, and cloud support for its precisionFDA platform—a secure, FISMA‑authorized, cloud‑based environment for genomics, multi‑omics, and regulatory science research. The contract will cover platform access licenses, AWS compute/storage, security patching, technical support, FedRAMP and FISMA compliance maintenance, integration with FDA enterprise systems, training, disaster recovery, and business continuity services. DNAnexus is identified as the only vendor capable of delivering Day‑1 continuity of all existing capabilities, with a $33 M estimated value and a performance period from 10 Aug 2026 to 9 Aug 2030. • Cloud‑based genomics platform (precisionFDA) support and modernization • AWS compute, storage, and data‑transfer services • FedRAMP Class C (Moderate) and FISMA High compliance maintenance • Integration with FDA systems (e.g., GSRS) and custom portal development • Training, user support, disaster recovery, and business continuity • Sole‑source award to DNAnexus; other vendors may submit capability statements within 15 days of notice.